PROTO LABS INC (PRLB)
US7437131094 - Common Stock
PRLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. While PRLB has a great health rating, its profitability is only average at the moment. PRLB is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PRLB was profitable.
PRLB had a positive operating cash flow in the past year.
Of the past 5 years PRLB 4 years were profitable.
Each year in the past 5 years PRLB had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PRLB (3.18%) is comparable to the rest of the industry.
PRLB has a Return On Equity of 3.53%. This is comparable to the rest of the industry: PRLB outperforms 40.77% of its industry peers.
With a Return On Invested Capital value of 2.63%, PRLB is not doing good in the industry: 68.46% of the companies in the same industry are doing better.
PRLB had an Average Return On Invested Capital over the past 3 years of 2.51%. This is significantly below the industry average of 11.13%.
The 3 year average ROIC (2.51%) for PRLB is below the current ROIC(2.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 3.53% | ||
| ROIC | 2.63% |
ROA(3y)-2.36%
ROA(5y)1.84%
ROE(3y)-2.78%
ROE(5y)2.09%
ROIC(3y)2.51%
ROIC(5y)4.14%
1.3 Margins
PRLB has a Profit Margin (4.76%) which is in line with its industry peers.
PRLB's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 5.92%, PRLB is in line with its industry, outperforming 43.08% of the companies in the same industry.
In the last couple of years the Operating Margin of PRLB has declined.
PRLB has a better Gross Margin (45.03%) than 85.38% of its industry peers.
In the last couple of years the Gross Margin of PRLB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.92% | ||
| PM (TTM) | 4.76% | ||
| GM | 45.03% |
OM growth 3Y-25.76%
OM growth 5Y-22.35%
PM growth 3Y-33.68%
PM growth 5Y-27.61%
GM growth 3Y-4.22%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
PRLB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PRLB has been reduced compared to a year ago.
2.2 Solvency
PRLB has an Altman-Z score of 9.53. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
PRLB has a Altman-Z score of 9.53. This is amongst the best in the industry. PRLB outperforms 91.54% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.01, PRLB belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PRLB (0.00) is better than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 9.53 |
ROIC/WACC0.29
WACC9.21%
2.3 Liquidity
PRLB has a Current Ratio of 3.59. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.59, PRLB belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
PRLB has a Quick Ratio of 3.36. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.36, PRLB belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.59 | ||
| Quick Ratio | 3.36 |
3. Growth
3.1 Past
PRLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.14%, which is quite impressive.
Measured over the past years, PRLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.05% on average per year.
The Revenue has been growing slightly by 1.96% in the past year.
The Revenue has been growing slightly by 2.49% on average over the past years.
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y-12.05%
EPS Q2Q%-7.84%
Revenue 1Y (TTM)1.96%
Revenue growth 3Y5.07%
Revenue growth 5Y2.49%
Sales Q2Q%-3.89%
3.2 Future
Based on estimates for the next years, PRLB will show a small growth in Earnings Per Share. The EPS will grow by 4.69% on average per year.
Based on estimates for the next years, PRLB will show a small growth in Revenue. The Revenue will grow by 3.12% on average per year.
EPS Next Y0.22%
EPS Next 2Y-2.21%
EPS Next 3Y4.69%
EPS Next 5YN/A
Revenue Next Year-0.46%
Revenue Next 2Y1.18%
Revenue Next 3Y3.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PRLB is valuated rather expensively with a Price/Earnings ratio of 23.58.
PRLB's Price/Earnings is on the same level as the industry average.
PRLB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.55.
A Price/Forward Earnings ratio of 26.35 indicates a quite expensive valuation of PRLB.
Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than 60.00% of the companies in the same industry.
PRLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.58 | ||
| Fwd PE | 26.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PRLB is valued a bit cheaper than 60.77% of the companies in the same industry.
76.15% of the companies in the same industry are more expensive than PRLB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.28 | ||
| EV/EBITDA | 13.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRLB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)109.67
PEG (5Y)N/A
EPS Next 2Y-2.21%
EPS Next 3Y4.69%
5. Dividend
5.1 Amount
No dividends for PRLB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PROTO LABS INC
NYSE:PRLB (12/26/2024, 8:04:00 PM)
After market: 40.32 0 (0%)40.32
+0.29 (+0.72%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners87.72%
Inst Owner Change0.82%
Ins Owners0.88%
Ins Owner Change0.14%
Market Cap988.24M
Analysts76.36
Price Target41.14 (2.03%)
Short Float %3.22%
Short Ratio2.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.52%
Min EPS beat(2)7.67%
Max EPS beat(2)43.37%
EPS beat(4)4
Avg EPS beat(4)31.16%
Min EPS beat(4)7.67%
Max EPS beat(4)48.11%
EPS beat(8)8
Avg EPS beat(8)31.19%
EPS beat(12)11
Avg EPS beat(12)28.28%
EPS beat(16)12
Avg EPS beat(16)19.01%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)1.46%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)5
Avg Revenue beat(8)1.11%
Revenue beat(12)6
Avg Revenue beat(12)0.36%
Revenue beat(16)8
Avg Revenue beat(16)0.04%
PT rev (1m)5.22%
PT rev (3m)5.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.05%
EPS NY rev (1m)2.08%
EPS NY rev (3m)12.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.65%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.58 | ||
| Fwd PE | 26.35 | ||
| P/S | 1.96 | ||
| P/FCF | 19.28 | ||
| P/OCF | 12.7 | ||
| P/B | 1.45 | ||
| P/tB | 2.58 | ||
| EV/EBITDA | 13.24 |
EPS(TTM)1.71
EY4.24%
EPS(NY)1.53
Fwd EY3.79%
FCF(TTM)2.09
FCFY5.19%
OCF(TTM)3.17
OCFY7.87%
SpS20.57
BVpS27.74
TBVpS15.63
PEG (NY)109.67
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 3.53% | ||
| ROCE | 4.26% | ||
| ROIC | 2.63% | ||
| ROICexc | 3.07% | ||
| ROICexgc | 6.07% | ||
| OM | 5.92% | ||
| PM (TTM) | 4.76% | ||
| GM | 45.03% | ||
| FCFM | 10.17% |
ROA(3y)-2.36%
ROA(5y)1.84%
ROE(3y)-2.78%
ROE(5y)2.09%
ROIC(3y)2.51%
ROIC(5y)4.14%
ROICexc(3y)2.83%
ROICexc(5y)5.2%
ROICexgc(3y)5.73%
ROICexgc(5y)8.42%
ROCE(3y)4.07%
ROCE(5y)6.72%
ROICexcg growth 3Y-16.78%
ROICexcg growth 5Y-22.21%
ROICexc growth 3Y-25.86%
ROICexc growth 5Y-25.87%
OM growth 3Y-25.76%
OM growth 5Y-22.35%
PM growth 3Y-33.68%
PM growth 5Y-27.61%
GM growth 3Y-4.22%
GM growth 5Y-3.83%
F-Score9
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 73.13% | ||
| Cap/Sales | 5.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 117.64% | ||
| Profit Quality | 213.67% | ||
| Current Ratio | 3.59 | ||
| Quick Ratio | 3.36 | ||
| Altman-Z | 9.53 |
F-Score9
WACC9.21%
ROIC/WACC0.29
Cap/Depr(3y)71.48%
Cap/Depr(5y)111.98%
Cap/Sales(3y)5.68%
Cap/Sales(5y)8.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y-12.05%
EPS Q2Q%-7.84%
EPS Next Y0.22%
EPS Next 2Y-2.21%
EPS Next 3Y4.69%
EPS Next 5YN/A
Revenue 1Y (TTM)1.96%
Revenue growth 3Y5.07%
Revenue growth 5Y2.49%
Sales Q2Q%-3.89%
Revenue Next Year-0.46%
Revenue Next 2Y1.18%
Revenue Next 3Y3.12%
Revenue Next 5YN/A
EBIT growth 1Y40.05%
EBIT growth 3Y-22%
EBIT growth 5Y-20.42%
EBIT Next Year70.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.43%
FCF growth 3Y-9.04%
FCF growth 5Y4.75%
OCF growth 1Y4.3%
OCF growth 3Y-11.86%
OCF growth 5Y-9.83%